Linked Data API

Show Search Form

Search Results

1139574
registered interest false more like this
date less than 2019-07-16more like thismore than 2019-07-16
answering body
Ministry of Defence more like this
answering dept id 11 more like this
answering dept short name Defence more like this
answering dept sort name Defence more like this
hansard heading Armed Forces: Mefloquine more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty's Government, further to the Written Answer by Baroness Blackwood of North Oxford on 10 July (HL16834), what steps the Ministry of Defence has taken to address the concerns of the European Medicines Agency Pharmacovigilance Assessment Committee 2014 report on the toxicity of mefloquine (Lariam); and if they have not taken any such steps, why not. more like this
tabling member printed
The Countess of Mar more like this
uin HL17221 more like this
answer
answer
is ministerial correction false more like this
date of answer remove filter
answer text <p>Anti-malarial drugs are prescribed to Service personnel with the UK product information leaflet. For mefloquine, this reflects the recommendations of the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency.</p><p>All anti-malarial drugs have contraindications and a side effect profile which can be found in the British National Formulary or online at the Electronic Medicines Compendium. It is Ministry of Defence policy that healthcare professionals undertake a health risk assessment and to warn patients of the possible side effects of any anti-malarial drug.</p> more like this
answering member printed Earl Howe more like this
question first answered
less than 2019-07-22T16:22:24.543Zmore like thismore than 2019-07-22T16:22:24.543Z
answering member
2000
label Biography information for Earl Howe more like this
tabling member
1861
label Biography information for The Countess of Mar more like this